MLICM
CDXS icon

Metropolitan Life Insurance Company (MetLife)’s Codexis CDXS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CDXS Stock Details CDXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,926
Closed -$6.72K – 396
2024
Q1 		$6.72K Sell
1,926
-1,463
-43% -$4.61K ﹤0.01% 2223
2023
Q4 		$10.3K Hold
3,389
– – ﹤0.01% 2170
2023
Q3 		$6.41K Hold
3,389
– – ﹤0.01% 2372
2023
Q2 		$9.49K Buy
3,389
+1,555
+85% +$5.03K ﹤0.01% 2326
2023
Q1 		$7.59K Sell
1,834
-2,027
-52% -$10.6K ﹤0.01% 2234
2022
Q4 		$18K Buy
3,861
+1,388
+56% +$7.61K ﹤0.01% 2072
2022
Q3 		$15K Sell
2,473
-1,588
-39% -$12.8K ﹤0.01% 2159
2022
Q2 		$42.5K Hold
4,061
– – ﹤0.01% 1604
2022
Q1 		$83.7K Sell
4,061
-11,784
-74% -$244K ﹤0.01% 1312
2021
Q4 		$495K Sell
15,845
-1,657
-9% -$54.5K 0.01% 1437
2021
Q3 		$407K Hold
17,502
– – 0.01% 1588
2021
Q2 		$397K Buy
17,502
+684
+4% +$14.8K 0.01% 1676
2021
Q1 		$385K Hold
16,818
– – 0.01% 1579
2020
Q4 		$367K Hold
16,818
– – 0.01% 1569
2020
Q3 		$197K Hold
16,818
– – ﹤0.01% 1785
2020
Q2 		$192K Hold
16,818
– – ﹤0.01% 1823
2020
Q1 		$188K Buy
16,818
+473
+3% +$6.61K ﹤0.01% 1627
2019
Q4 		$261K Sell
16,345
-865
-5% -$12.8K ﹤0.01% 1737
2019
Q3 		$236K Hold
17,210
– – ﹤0.01% 1765
2019
Q2 		$317K Hold
17,210
– – 0.01% 1584
2019
Q1 		$353K Hold
17,210
– – 0.01% 1519
2018
Q4 		$287K Hold
17,210
– – 0.01% 1570
2018
Q3 		$295K Hold
17,210
– – 0.01% 1727
2018
Q2 		$248K Buy
17,210
+3,475
+25% +$45.3K ﹤0.01% 1800
2018
Q1 		$151K Buy
13,735
+2,856
+26% +$27.3K ﹤0.01% 2068
2017
Q4 		$91K Sell
10,879
-17,558
-62% -$122K ﹤0.01% 2359
2017
Q3 		$189K Buy
+28,437
New +$157K ﹤0.01% 2307

Other funds holding CDXS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CDXS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Codexis (CDXS) in Q2 2024, closing a stake of 1,926 shares — an estimated $6.72K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CDXS in Q3 2017 and held it in 27 quarters. The position peaked at $495K in Q4 2021. 118 funds tracked by Wall St. Rank hold CDXS as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Codexis position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,926 Codexis shares in Q2 2024, an estimated $6.72K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Codexis in Q3 2017 and held it in 27 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Codexis position peaked at $495K in Q4 2021.
  • 118 funds tracked by Wall St. Rank held Codexis as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.